Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Students urge PBM and 340B transparency, propose 20% cap on hospital drug markups
Summary
Middlebury College students told the House Health Care Committee May 14 that Vermont should increase transparency of pharmacy benefit managers and 340B revenues and consider capping hospital-administered drug reimbursements to curb high prescription costs.
Middlebury College students told the Vermont House Health Care Committee May 14 at the State House that pharmacy benefit managers (PBMs) and the 340B drug-pricing program are contributing to high prescription costs and recommended state-level reporting and price limits.
The students said greater transparency and reporting from PBMs and hospitals would show where discounts and markups flow and help regulators spot “spread pricing” that diverts savings away from patients. They recommended requiring PBMs to submit an annual reimbursement report and hospitals to report 340B revenue and usage, then consider a 20% cap on commercial reimbursement for hospital‑administered drugs.
Student presenter Ellie Kennedy said PBMs “act as middlemen between manufacturers and pharmacies” and that their markups are often…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
